Noveome Biotherapeutics is Biotechnology in United States that focus on vascular integrity business. Founded in 2000. They cover business area such as developer, novel biotherapeutic product, inflame or damage tissue, numerous biologic component, physiologic concentration, combination, inflammatory, neuroprotective, anti-apoptotic and vascular integrity preservative activity, healthcare provider, treatment, complex disease.
2000
( 24 years old in 2024 )
Vascular Integrity
-
100 Technology Drive
Suite 200
Pittsburgh, PA 15219
United States
Private
developernovel biotherapeutic productinflame or damage tissuenumerous biologic componentphysiologic concentrationcombinationinflammatory, neuroprotective, anti-apoptotic and vascular integrity preservative activityhealthcare providertreatmentcomplex disease
* We use standard office opening hours in near Noveome Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Noveome Biotherapeutics is Biotechnology business from United States that founded in 2000 (24 years old in 2024), Noveome Biotherapeutics business is focusing on Vascular Integrity.
Noveome Biotherapeutics headquarter office and corporate office address is located in 100 Technology Drive Suite 200 Pittsburgh, PA 15219 United States.
Noveome Biotherapeutics was founded in United States.
In 2024, Noveome Biotherapeutics is currently focus on vascular integrity sector.
Above is snippet of Google Trends for "vascular integrity" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Noveome Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
